Risk Factors for Community- and Workplace Transmission of COVID-19
1 other identifier
observational
250,000
1 country
1
Brief Summary
The project is an epidemiological observational study based on an electronic questionnaire on risk factors for COVID-19 in the community and healthcare setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2020
CompletedFirst Posted
Study publicly available on registry
March 25, 2020
CompletedStudy Start
First participant enrolled
March 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2030
ExpectedDecember 13, 2021
November 1, 2021
5 years
March 23, 2020
November 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of COVID-19 infection
Diagnosed with serology or direct viral detection
1 year
Study Arms (5)
Individuals with COVID-19 infection
Confirmed by routine laboratory diagnosis. All types of COVID-19 disease from asymptomatic carriers to hospitalized patients can be included. Only subjects \>18 years old will be included in the study.
Individuals tested for COVID-19 infection with negative test
Confirmed by routine laboratory diagnosis
Healthy individuals
Recruitet from the general population
Risk groups for COVID-19 exposure
Including, but not limited to healthcare workers.
Patients admitted to hospital
Without COVID-19 infection.
Interventions
No intervention, only prospective observation of behavior will be conducted by a questionnaire.
Eligibility Criteria
The study will be a combined retrospective and prospective case-control study based on a combined electronic consent form and questionnaire that the study groups will fill in using a smartphone and electronic identification. The groups that will be included are: * Hospitalized and non-hospitalized patients/persons with COVID-19 at all stages of the disease and after the disease * Hospitalized patients without COVID-19 * Healthcare personal or other groups with an increased risk of COVID-19 * Healthy volunteers Probability sampling will be conducted, but not solely.
You may qualify if:
- Norwegian adult
You may not qualify if:
- Unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- Age Labs AScollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
Biospecimen
Blood and upper repiratory samples will be collected from some participants.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, MD, PhD
Study Record Dates
First Submitted
March 23, 2020
First Posted
March 25, 2020
Study Start
March 27, 2020
Primary Completion
March 27, 2025
Study Completion (Estimated)
March 20, 2030
Last Updated
December 13, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
European GDPR regulations severely limits IPD, but the study will share data to the largest extent possible within GDPR.